| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.947 | 0.002 | 0.947 | Vasodilator, peripheral | 0.929 0.002 DBMET02771 0.865 0.003 DBMET02772 0.765 0.004 DBMET02773 | ||
| 0.843 | 0.004 | 0.887 | Platelet antagonist | 0.887 0.004 DBMET02771 0.879 0.004 DBMET02772 0.751 0.005 DBMET02773 | DBMET02771 | |
| 0.834 | 0.004 | 0.834 | Antithrombotic | 0.824 0.004 DBMET02771 0.72 0.007 DBMET02772 0.66 0.011 DBMET02773 | ||
| 0.742 | 0 | 0.742 | Prostaglandin agonist | 0.684 0 DBMET02771 0.614 0.001 DBMET02772 0.489 0.001 DBMET02773 | ||
| 0.74 | 0 | 0.74 | Prostaglandin E2 agonist | 0.697 0 DBMET02771 0.551 0.001 DBMET02772 0.497 0.001 DBMET02773 | ||
| 0.711 | 0.001 | 0.791 | Prostaglandin F2 alpha antagonist | 0.791 0.001 DBMET02771 0.764 0.001 DBMET02772 0.677 0.001 DBMET02773 | DBMET02771 | |
| 0.701 | 0.005 | 0.723 | Hypolipemic | 0.708 0.005 DBMET02771 0.723 0.004 DBMET02772 0.723 0.004 DBMET02773 | DBMET02773 | |
| 0.677 | 0.01 | 0.677 | Cholesterol antagonist | 0.669 0.01 DBMET02771 0.564 0.023 DBMET02772 0.601 0.019 DBMET02773 | ||
| 0.65 | 0.009 | 0.65 | Spasmolytic | 0.558 0.017 DBMET02771 0.438 0.033 DBMET02772 0.442 0.032 DBMET02773 | ||
| 0.606 | 0.005 | 0.614 | Vasodilator | 0.614 0.005 DBMET02771 0.572 0.007 DBMET02772 0.515 0.011 DBMET02773 | DBMET02771 | |
| 0.601 | 0.002 | 0.694 | Prostaglandin EP2 antagonist | 0.694 0.002 DBMET02771 0.67 0.002 DBMET02772 0.617 0.002 DBMET02773 | DBMET02771 | |
| 0.603 | 0.005 | 0.679 | Platelet aggregation inhibitor | 0.679 0.005 DBMET02771 0.589 0.005 DBMET02772 0.487 0.01 DBMET02773 | DBMET02771 | |
| 0.601 | 0.031 | 0.605 | Transcription factor NF kappa B inhibitor | 0.605 0.031 DBMET02771 0.497 0.045 DBMET02772 0.461 0.051 DBMET02773 | DBMET02771 | |
| 0.577 | 0.016 | 0.603 | Immunosuppressant | 0.603 0.013 DBMET02771 0.575 0.016 DBMET02772 0.55 0.021 DBMET02773 | DBMET02771 | |
| 0.562 | 0.002 | 0.747 | Prostaglandin EP4 antagonist | 0.747 0.001 DBMET02771 0.602 0.001 DBMET02772 0.5 0.002 DBMET02773 | DBMET02771 | |
| 0.61 | 0.051 | 0.637 | Antiinflammatory | 0.637 0.044 DBMET02771 0.574 0.061 DBMET02772 0.506 0.085 DBMET02773 | DBMET02771 | |
| 0.562 | 0.004 | 0.735 | Prostaglandin antagonist | 0.735 0.003 DBMET02771 0.714 0.003 DBMET02772 0.478 0.004 DBMET02773 | DBMET02771 | |
| 0.546 | 0.001 | 0.546 | Prostaglandin EP2 agonist | 0.513 0.001 DBMET02771 0.394 0.001 DBMET02772 0.3 0.001 DBMET02773 | ||
| 0.543 | 0.021 | 0.721 | 5 Hydroxytryptamine release stimulant | 0.522 0.024 DBMET02771 0.564 0.018 DBMET02772 0.721 0.006 DBMET02773 | DBMET02773 | |
| 0.539 | 0.024 | 0.539 | Immunostimulant | 0.507 0.028 DBMET02771 0.428 0.042 DBMET02772 0.449 0.037 DBMET02773 | ||
| 0.514 | 0.002 | 0.713 | Thromboxane antagonist | 0.713 0.001 DBMET02771 0.604 0.002 DBMET02772 0.388 0.002 DBMET02773 | DBMET02771 | |
| 0.514 | 0.002 | 0.721 | Thromboxane A2 antagonist | 0.721 0.001 DBMET02771 0.61 0.001 DBMET02772 0.388 0.002 DBMET02773 | DBMET02771 | |
| 0.494 | 0.009 | 0.494 | Interleukin agonist | 0.444 0.013 DBMET02771 0.409 0.017 DBMET02772 0.453 0.013 DBMET02773 | ||
| 0.521 | 0.044 | 0.672 | Cyclophilin D inhibitor | 0.566 0.034 DBMET02771 0.542 0.039 DBMET02772 0.672 0.017 DBMET02773 | DBMET02773 | |
| 0.453 | 0.001 | 0.5 | Prostaglandin D2 agonist | 0.5 0.001 DBMET02771 0.481 0.001 DBMET02772 0.396 0.001 DBMET02773 | DBMET02771 | |
| 0.456 | 0.02 | 0.501 | Hypoglycemic | 0.433 0.023 DBMET02771 0.391 0.029 DBMET02772 0.501 0.015 DBMET02773 | DBMET02773 | |
| 0.443 | 0.008 | 0.484 | Bone formation stimulant | 0.46 0.007 DBMET02771 0.484 0.006 DBMET02772 0.458 0.008 DBMET02773 | DBMET02772 | |
| 0.496 | 0.076 | 0.508 | Apoptosis agonist | 0.508 0.072 DBMET02771 0.501 0.074 DBMET02772 0.305 0.168 DBMET02773 | DBMET02771 | |
| 0.418 | 0.005 | 0.418 | Insulin sensitizer | 0.385 0.007 DBMET02771 0.294 0.017 DBMET02772 0.367 0.008 DBMET02773 | ||
| 0.417 | 0.004 | 0.514 | Gastrin inhibitor | 0.514 0.003 DBMET02771 0.474 0.004 DBMET02772 0.366 0.008 DBMET02773 | DBMET02771 | |
| 0.422 | 0.011 | 0.455 | Non-steroidal antiinflammatory agent | 0.455 0.009 DBMET02771 0.345 0.02 DBMET02772 0.314 0.025 DBMET02773 | DBMET02771 | |
| 0.412 | 0.004 | 0.425 | Gastric antisecretory | 0.425 0.004 DBMET02771 0.404 0.004 DBMET02772 0.246 0.007 DBMET02773 | DBMET02771 | |
| 0.477 | 0.07 | 0.639 | Caspase 9 stimulant | 0.639 0.031 DBMET02771 0.461 0.077 DBMET02772 0.406 0.107 DBMET02773 | DBMET02771 | |
| 0.408 | 0.004 | 0.462 | Cholesterol synthesis inhibitor | 0.461 0.003 DBMET02771 0.419 0.004 DBMET02772 0.462 0.003 DBMET02773 | DBMET02773 | |
| 0.4 | 0 | 0.4 | Prostaglandin F2 alpha agonist | 0.3 0 DBMET02771 0.201 0 DBMET02772 0.17 0.001 DBMET02773 | ||
| 0.408 | 0.011 | 0.441 | Platelet adhesion inhibitor | 0.441 0.008 DBMET02771 0.39 0.013 DBMET02772 0.351 0.019 DBMET02773 | DBMET02771 | |
| 0.451 | 0.056 | 0.451 | Antibacterial | 0.447 0.058 DBMET02771 0.433 0.063 DBMET02772 0.382 0.085 DBMET02773 | ||
| 0.387 | 0.001 | 0.387 | Prostaglandin EP4 agonist | 0.376 0.001 DBMET02771 0.286 0.001 DBMET02772 0.218 0.001 DBMET02773 | ||
| 0.393 | 0.008 | 0.393 | Hemostatic | 0.388 0.009 DBMET02771 0.284 0.017 DBMET02772 0.221 0.026 DBMET02773 | ||
| 0.396 | 0.012 | 0.453 | Melanin inhibitor | 0.453 0.009 DBMET02771 0.368 0.014 DBMET02772 0.387 0.013 DBMET02773 | DBMET02771 | |
| 0.404 | 0.021 | 0.458 | Angiogenesis stimulant | 0.458 0.015 DBMET02771 0.39 0.023 DBMET02772 0.338 0.036 DBMET02773 | DBMET02771 | |
| 0.42 | 0.039 | 0.467 | Caspase 3 stimulant | 0.467 0.026 DBMET02771 0.413 0.041 DBMET02772 0.248 0.114 DBMET02773 | DBMET02771 | |
| 0.41 | 0.035 | 0.468 | Apoptosis antagonist | 0.468 0.025 DBMET02771 0.381 0.044 DBMET02772 0.455 0.027 DBMET02773 | DBMET02771 | |
| 0.381 | 0.009 | 0.381 | Protein kinase stimulant | 0.355 0.011 DBMET02771 0.238 0.03 DBMET02772 0.256 0.025 DBMET02773 | ||
| 0.428 | 0.061 | 0.531 | Histamine release inhibitor | 0.432 0.059 DBMET02771 0.372 0.09 DBMET02772 0.531 0.02 DBMET02773 | DBMET02773 | |
| 0.37 | 0.004 | 0.486 | Prostaglandin E2 antagonist | 0.486 0.003 DBMET02771 0.466 0.004 DBMET02772 0.433 0.004 DBMET02773 | DBMET02771 | |
| 0.379 | 0.015 | 0.379 | Hepatoprotectant | 0.334 0.022 DBMET02771 0.305 0.028 DBMET02772 0.29 0.032 DBMET02773 | ||
| 0.4 | 0.044 | 0.4 | Immunomodulator | 0.318 0.072 DBMET02771 0.365 0.055 DBMET02772 0.308 0.078 DBMET02773 | ||
| 0.341 | 0.003 | 0.453 | Prostaglandin EP3 antagonist | 0.453 0.002 DBMET02771 0.445 0.002 DBMET02772 0.432 0.002 DBMET02773 | DBMET02771 | |
| 0.332 | 0.003 | 0.499 | Prostaglandin EP1 antagonist | 0.499 0.003 DBMET02771 0.473 0.003 DBMET02772 0.38 0.003 DBMET02773 | DBMET02771 | |
| 0.361 | 0.041 | 0.431 | Interleukin 2 agonist | 0.431 0.019 DBMET02771 0.413 0.024 DBMET02772 0.403 0.026 DBMET02773 | DBMET02771 | |
| 0.323 | 0.017 | 0.369 | Interferon gamma antagonist | 0.369 0.013 DBMET02771 0.34 0.015 DBMET02772 0.33 0.016 DBMET02773 | DBMET02771 | |
| 0.318 | 0.026 | 0.325 | P-glycoprotein inhibitor | 0.269 0.036 DBMET02771 0.325 0.025 DBMET02772 0.268 0.036 DBMET02773 | DBMET02772 | |
| 0.324 | 0.036 | 0.337 | Nitric oxide antagonist | 0.337 0.034 DBMET02771 0.311 0.038 DBMET02772 0.296 0.041 DBMET02773 | DBMET02771 | |
| 0.335 | 0.05 | 0.34 | Antioxidant | 0.34 0.049 DBMET02771 0.278 0.071 DBMET02772 0.275 0.072 DBMET02773 | DBMET02771 | |
| 0.326 | 0.057 | 0.405 | Sodium/bile acid cotransporter inhibitor | 0.377 0.025 DBMET02771 0.378 0.025 DBMET02772 0.405 0.015 DBMET02773 | DBMET02773 | |
| 0.283 | 0.016 | 0.312 | Phospholipase A2 inhibitor | 0.312 0.012 DBMET02771 0.217 0.035 DBMET02772 0.268 0.019 DBMET02773 | DBMET02771 | |
| 0.257 | 0.002 | 0.312 | Prostacyclin agonist | 0.312 0.002 DBMET02771 0.283 0.002 DBMET02772 0.24 0.002 DBMET02773 | DBMET02771 | |
| 0.26 | 0.005 | 0.295 | TRPA1 agonist | 0.295 0.005 DBMET02771 0.202 0.01 DBMET02772 0.15 0.031 DBMET02773 | DBMET02771 | |
| 0.304 | 0.052 | 0.304 | Tumour necrosis factor alpha release inhibitor | 0.26 0.07 DBMET02771 0.172 0.132 DBMET02772 0.219 0.093 DBMET02773 | ||
| 0.258 | 0.007 | 0.258 | Microtubule formation inhibitor | 0.239 0.012 DBMET02771 0.219 0.016 DBMET02772 0.215 0.017 DBMET02773 | ||
| 0.317 | 0.074 | 0.37 | Vasodilator, coronary | 0.255 0.129 DBMET02771 0.269 0.115 DBMET02772 0.37 0.046 DBMET02773 | DBMET02773 | |
| 0.25 | 0.017 | 0.257 | DNA polymerase I inhibitor | 0.257 0.016 DBMET02771 0.217 0.023 DBMET02772 0.22 0.023 DBMET02773 | DBMET02771 | |
| 0.237 | 0.012 | 0.237 | Toll-Like receptor 2 antagonist | 0.205 0.022 DBMET02771 0.154 0.05 DBMET02772 0.183 0.032 DBMET02773 | ||
| 0.239 | 0.027 | 0.41 | Phospholipase C inhibitor | 0.41 0.01 DBMET02771 0.249 0.025 DBMET02772 0.292 0.019 DBMET02773 | DBMET02771 | |
| 0.216 | 0.005 | 0.276 | Leukotriene antagonist | 0.276 0.004 DBMET02771 0.234 0.005 DBMET02772 0.207 0.005 DBMET02773 | DBMET02771 | |
| 0.208 | 0.001 | 0.357 | Thromboxane agonist | 0.357 0 DBMET02771 0.234 0 DBMET02772 0.165 0.001 DBMET02773 | DBMET02771 | |
| 0.253 | 0.049 | 0.309 | Peptidyltransferase inhibitor | 0.269 0.039 DBMET02771 0.285 0.031 DBMET02772 0.309 0.022 DBMET02773 | DBMET02773 | |
| 0.22 | 0.017 | 0.227 | Arachidonic acid antagonist | 0.227 0.013 DBMET02771 0.208 0.026 DBMET02772 0.224 0.015 DBMET02773 | DBMET02771 | |
| 0.246 | 0.052 | 0.246 | RNA-directed DNA polymerase inhibitor | 0.171 0.149 DBMET02771 0.171 0.151 DBMET02773 | ||
| 0.252 | 0.061 | 0.273 | Interleukin antagonist | 0.273 0.054 DBMET02771 0.176 0.099 DBMET02772 0.186 0.092 DBMET02773 | DBMET02771 | |
| 0.199 | 0.022 | 0.219 | Farnesoid X receptor antagonist | 0.219 0.017 DBMET02771 0.186 0.026 DBMET02772 0.161 0.042 DBMET02773 | DBMET02771 | |
| 0.193 | 0.017 | 0.227 | Adenylate cyclase stimulant | 0.227 0.006 DBMET02771 0.203 0.012 DBMET02772 0.215 0.008 DBMET02773 | DBMET02771 | |
| 0.211 | 0.042 | 0.22 | Antipruritic | 0.218 0.038 DBMET02771 0.147 0.098 DBMET02772 0.22 0.037 DBMET02773 | DBMET02773 | |
| 0.185 | 0.016 | 0.203 | Vanilloid 1 agonist | 0.203 0.011 DBMET02771 0.161 0.029 DBMET02772 0.165 0.026 DBMET02773 | DBMET02771 | |
| 0.171 | 0.004 | 0.248 | Leukotriene B4 antagonist | 0.248 0.003 DBMET02771 0.162 0.005 DBMET02772 0.195 0.004 DBMET02773 | DBMET02771 | |
| 0.213 | 0.054 | 0.309 | Growth hormone agonist | 0.309 0.03 DBMET02771 0.228 0.049 DBMET02772 0.304 0.032 DBMET02773 | DBMET02771 | |
| 0.196 | 0.043 | 0.218 | Interleukin 6 antagonist | 0.218 0.032 DBMET02771 0.175 0.059 DBMET02772 | DBMET02771 | |
| 0.184 | 0.035 | 0.224 | Neurotrophic factor | 0.224 0.018 DBMET02771 0.189 0.033 DBMET02772 0.208 0.024 DBMET02773 | DBMET02771 | |
| 0.193 | 0.044 | 0.243 | ATPase inhibitor | 0.243 0.015 DBMET02771 0.218 0.025 DBMET02772 0.203 0.035 DBMET02773 | DBMET02771 | |
| 0.179 | 0.038 | 0.179 | Monophenol monooxygenase inhibitor | 0.142 0.05 DBMET02771 0.096 0.079 DBMET02772 0.149 0.047 DBMET02773 | ||
| 0.157 | 0.017 | 0.157 | Toll-Like receptor 4 antagonist | 0.157 0.017 DBMET02771 0.133 0.032 DBMET02772 0.135 0.03 DBMET02773 | ||
| 0.147 | 0.011 | 0.184 | Vanilloid agonist | 0.184 0.008 DBMET02771 0.114 0.021 DBMET02772 0.103 0.03 DBMET02773 | DBMET02771 | |
| 0.15 | 0.018 | 0.168 | Anabolic | 0.164 0.012 DBMET02771 0.149 0.019 DBMET02772 0.168 0.01 DBMET02773 | DBMET02773 | |
| 0.231 | 0.1 | 0.231 | Transcription factor STAT3 inhibitor | |||
| 0.141 | 0.015 | 0.155 | Peroxisome proliferator-activated receptor gamma agonist | 0.155 0.012 DBMET02771 0.136 0.016 DBMET02772 0.153 0.012 DBMET02773 | DBMET02771 | |
| 0.155 | 0.03 | 0.165 | Bronchodilator | 0.165 0.026 DBMET02771 0.138 0.036 DBMET02772 0.151 0.031 DBMET02773 | DBMET02771 | |
| 0.146 | 0.023 | 0.151 | Electron transport complex I inhibitor | 0.151 0.02 DBMET02771 0.133 0.032 DBMET02772 0.134 0.032 DBMET02773 | DBMET02771 | |
| 0.174 | 0.053 | 0.211 | NOS3 expression enhancer | 0.211 0.037 DBMET02771 0.197 0.042 DBMET02772 0.162 0.062 DBMET02773 | DBMET02771 | |
| 0.21 | 0.09 | 0.211 | Free radical scavenger | 0.211 0.089 DBMET02771 0.168 0.125 DBMET02772 0.191 0.105 DBMET02773 | DBMET02771 | |
| 0.217 | 0.098 | 0.227 | DNA synthesis inhibitor | 0.214 0.103 DBMET02771 0.193 0.133 DBMET02772 0.227 0.086 DBMET02773 | DBMET02773 | |
| 0.197 | 0.08 | 0.228 | Neurotrophic factor enhancer | 0.201 0.076 DBMET02771 0.172 0.108 DBMET02772 0.228 0.052 DBMET02773 | DBMET02773 | |
| 0.12 | 0.004 | 0.12 | Nitric oxide donor | 0.118 0.004 DBMET02771 0.114 0.004 DBMET02772 0.11 0.005 DBMET02773 | ||
| 0.122 | 0.009 | 0.122 | Peroxisome proliferator-activated receptor alpha agonist | 0.105 0.011 DBMET02771 0.073 0.021 DBMET02772 0.12 0.009 DBMET02773 | ||
| 0.156 | 0.043 | 0.156 | Cyclooxygenase 3 inhibitor | 0.102 0.1 DBMET02771 0.152 0.046 DBMET02773 | ||
| 0.129 | 0.021 | 0.129 | Transcription factor NF kappa B stimulant | 0.116 0.027 DBMET02771 0.087 0.055 DBMET02772 | ||
| 0.124 | 0.017 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 DBMET02771 0.134 0.012 DBMET02772 0.124 0.017 DBMET02773 | DBMET02772 | |
| 0.137 | 0.034 | 0.142 | Antineoplastic antibiotic | 0.139 0.033 DBMET02771 0.142 0.033 DBMET02772 0.118 0.039 DBMET02773 | DBMET02772 | |
| 0.138 | 0.036 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.026 DBMET02771 0.115 0.053 DBMET02772 0.144 0.032 DBMET02773 | DBMET02771 | |
| 0.25 | 0.148 | 0.314 | Toll-Like receptor agonist | 0.298 0.112 DBMET02771 0.258 0.141 DBMET02772 0.314 0.102 DBMET02773 | DBMET02773 | |
| 0.12 | 0.02 | 0.121 | Bile acid receptor antagonist | 0.118 0.022 DBMET02771 0.101 0.047 DBMET02772 0.121 0.019 DBMET02773 | DBMET02773 | |
| 0.163 | 0.065 | 0.203 | Hexokinase inhibitor | 0.199 0.036 DBMET02771 0.203 0.034 DBMET02772 0.155 0.073 DBMET02773 | DBMET02772 | |
| 0.147 | 0.05 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 DBMET02771 0.146 0.052 DBMET02772 0.156 0.03 DBMET02773 | DBMET02773 | |
| 0.115 | 0.02 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 DBMET02771 0.113 0.021 DBMET02772 0.123 0.015 DBMET02773 | DBMET02773 | |
| 0.146 | 0.051 | 0.146 | Anesthetic local | 0.098 0.085 DBMET02773 | ||
| 0.115 | 0.02 | 0.115 | Lipase inhibitor | 0.094 0.031 DBMET02771 | ||
| 0.114 | 0.02 | 0.135 | Interferon agonist | 0.108 0.023 DBMET02771 0.088 0.041 DBMET02772 0.135 0.013 DBMET02773 | DBMET02773 | |
| 0.13 | 0.036 | 0.231 | Adenylate kinase inhibitor | 0.231 0.011 DBMET02771 0.165 0.022 DBMET02772 0.182 0.018 DBMET02773 | DBMET02771 | |
| 0.129 | 0.035 | 0.318 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.218 0.013 DBMET02771 0.193 0.017 DBMET02772 0.318 0.005 DBMET02773 | DBMET02773 | |
| 0.156 | 0.065 | 0.156 | Lipid peroxidase inhibitor | 0.142 0.074 DBMET02771 0.127 0.087 DBMET02773 | ||
| 0.092 | 0.003 | 0.105 | HMG CoA reductase inhibitor | 0.098 0.002 DBMET02771 0.101 0.002 DBMET02772 0.105 0.002 DBMET02773 | DBMET02773 | |
| 0.094 | 0.007 | 0.17 | Thromboxane synthase inhibitor | 0.17 0.004 DBMET02771 0.116 0.005 DBMET02772 0.073 0.016 DBMET02773 | DBMET02771 | |
| 0.09 | 0.005 | 0.138 | Prostacyclin antagonist | 0.138 0.004 DBMET02771 0.114 0.004 DBMET02772 0.06 0.009 DBMET02773 | DBMET02771 | |
| 0.093 | 0.01 | 0.102 | Sphingosine kinase inhibitor | 0.102 0.007 DBMET02771 0.077 0.018 DBMET02772 0.09 0.011 DBMET02773 | DBMET02771 | |
| 0.106 | 0.023 | 0.14 | Leukotriene synthesis inhibitor | 0.14 0.011 DBMET02771 0.111 0.02 DBMET02772 0.106 0.023 DBMET02773 | DBMET02771 | |
| 0.086 | 0.007 | 0.086 | Squalene synthetase inhibitor | 0.071 0.009 DBMET02771 0.059 0.012 DBMET02772 0.058 0.012 DBMET02773 | ||
| 0.077 | 0.001 | 0.159 | Thromboxane A2 agonist | 0.159 0.001 DBMET02771 0.095 0.001 DBMET02772 0.063 0.002 DBMET02773 | DBMET02771 | |
| 0.137 | 0.063 | 0.441 | Alpha-N-acetylglucosaminidase inhibitor | 0.218 0.029 DBMET02771 0.28 0.018 DBMET02772 0.441 0.007 DBMET02773 | DBMET02773 | |
| 0.12 | 0.051 | 0.176 | Expectorant | 0.16 0.031 DBMET02771 0.134 0.042 DBMET02772 0.176 0.026 DBMET02773 | DBMET02773 | |
| 0.076 | 0.011 | 0.078 | Vanilloid 2 antagonist | 0.078 0.01 DBMET02771 0.064 0.019 DBMET02772 0.053 0.034 DBMET02773 | DBMET02771 | |
| 0.091 | 0.026 | 0.091 | Elastase 1 inhibitor | 0.066 0.052 DBMET02771 | ||
| 0.068 | 0.005 | 0.149 | Prostaglandin D2 antagonist | 0.149 0.004 DBMET02771 0.132 0.004 DBMET02772 0.024 0.015 DBMET02773 | DBMET02771 | |
| 0.157 | 0.095 | 0.221 | Lipocortins synthesis antagonist | 0.203 0.054 DBMET02771 0.18 0.071 DBMET02772 0.221 0.045 DBMET02773 | DBMET02773 | |
| 0.082 | 0.022 | 0.102 | Interferon inducer | 0.082 0.022 DBMET02771 0.067 0.039 DBMET02772 0.102 0.012 DBMET02773 | DBMET02773 | |
| 0.198 | 0.139 | 0.341 | Tyrosine 3 hydroxylase inhibitor | 0.25 0.068 DBMET02771 0.286 0.04 DBMET02772 0.341 0.018 DBMET02773 | DBMET02773 | |
| 0.062 | 0.003 | 0.152 | Prostaglandin H2 antagonist | 0.152 0.002 DBMET02771 0.105 0.002 DBMET02772 0.062 0.003 DBMET02773 | DBMET02771 | |
| 0.1 | 0.045 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.026 DBMET02771 0.104 0.04 DBMET02772 0.114 0.03 DBMET02773 | DBMET02771 | |
| 0.121 | 0.066 | 0.181 | Adenylate cyclase inhibitor | 0.096 0.088 DBMET02771 0.112 0.074 DBMET02772 0.181 0.03 DBMET02773 | DBMET02773 | |
| 0.076 | 0.021 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.078 0.02 DBMET02771 0.078 0.02 DBMET02772 0.078 0.02 DBMET02773 | DBMET02773 | |
| 0.068 | 0.015 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | 0.068 0.016 DBMET02771 0.047 0.04 DBMET02772 0.048 0.038 DBMET02773 | ||
| 0.054 | 0.002 | 0.061 | Vitamin D receptor agonist | 0.061 0.002 DBMET02771 0.038 0.003 DBMET02772 0.042 0.003 DBMET02773 | DBMET02771 | |
| 0.105 | 0.054 | 0.129 | Sphingomyelinase inhibitor | 0.129 0.035 DBMET02771 0.103 0.056 DBMET02772 0.085 0.079 DBMET02773 | DBMET02771 | |
| 0.067 | 0.017 | 0.086 | Leukotriene C antagonist | 0.086 0.006 DBMET02771 0.07 0.014 DBMET02772 0.074 0.011 DBMET02773 | DBMET02771 | |
| 0.087 | 0.037 | 0.226 | Phosphofructokinase-1 inhibitor | 0.191 0.012 DBMET02771 0.174 0.014 DBMET02772 0.226 0.009 DBMET02773 | DBMET02773 | |
| 0.061 | 0.013 | 0.061 | Microtubule stabilization | 0.056 0.02 DBMET02771 0.053 0.024 DBMET02772 0.053 0.024 DBMET02773 | ||
| 0.073 | 0.025 | 0.114 | Acyl-CoA dehydrogenase inhibitor | 0.114 0.014 DBMET02771 0.096 0.017 DBMET02772 0.112 0.014 DBMET02773 | DBMET02771 | |
| 0.057 | 0.011 | 0.063 | Sphingosine kinase 1 inhibitor | 0.063 0.008 DBMET02771 0.05 0.016 DBMET02772 0.06 0.009 DBMET02773 | DBMET02771 | |
| 0.106 | 0.06 | 0.117 | Protease inhibitor | 0.102 0.063 DBMET02771 0.093 0.072 DBMET02772 0.117 0.05 DBMET02773 | DBMET02773 | |
| 0.08 | 0.037 | 0.095 | Selectin antagonist | 0.095 0.03 DBMET02771 0.063 0.047 DBMET02772 0.071 0.042 DBMET02773 | DBMET02771 | |
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.044 DBMET02771 0.076 0.04 DBMET02773 | ||
| 0.044 | 0.005 | 0.044 | Lysophosphatidic acid receptor 1 agonist | 0.033 0.008 DBMET02771 0.024 0.02 DBMET02772 0.024 0.019 DBMET02773 | ||
| 0.06 | 0.021 | 0.064 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET02771 0.048 0.032 DBMET02772 0.064 0.017 DBMET02773 | DBMET02773 | |
| 0.06 | 0.021 | 0.06 | Oleamide hydrolase inhibitor | |||
| 0.057 | 0.02 | 0.064 | Cholesterol esterase inhibitor | 0.046 0.036 DBMET02771 0.064 0.014 DBMET02773 | DBMET02773 | |
| 0.112 | 0.076 | 0.118 | Alkylator | 0.118 0.07 DBMET02771 | DBMET02771 | |
| 0.064 | 0.028 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 DBMET02771 0.06 0.035 DBMET02772 0.063 0.03 DBMET02773 | DBMET02771 | |
| 0.084 | 0.051 | 0.101 | T cell inhibitor | 0.093 0.032 DBMET02771 0.089 0.04 DBMET02772 0.101 0.023 DBMET02773 | DBMET02773 | |
| 0.058 | 0.027 | 0.062 | Antimetabolite | 0.062 0.024 DBMET02771 0.041 0.04 DBMET02772 0.058 0.027 DBMET02773 | DBMET02771 | |
| 0.041 | 0.009 | 0.041 | Calcium-independent phospholipase A2 inhibitor | 0.04 0.01 DBMET02771 0.034 0.025 DBMET02772 0.033 0.028 DBMET02773 | ||
| 0.046 | 0.015 | 0.047 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.047 0.014 DBMET02771 0.037 0.025 DBMET02772 0.044 0.016 DBMET02773 | DBMET02771 | |
| 0.042 | 0.012 | 0.129 | ATP citrate lysase inhibitor | 0.11 0.003 DBMET02771 0.07 0.004 DBMET02772 0.129 0.003 DBMET02773 | DBMET02773 | |
| 0.077 | 0.048 | 0.17 | Glutamate dehydrogenase inhibitor | 0.134 0.019 DBMET02771 0.124 0.022 DBMET02772 0.17 0.013 DBMET02773 | DBMET02773 | |
| 0.054 | 0.024 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.09 0.006 DBMET02771 0.083 0.008 DBMET02772 0.1 0.005 DBMET02773 | DBMET02773 | |
| 0.044 | 0.017 | 0.06 | Leukotriene C4 antagonist | 0.06 0.006 DBMET02771 0.046 0.014 DBMET02772 0.049 0.011 DBMET02773 | DBMET02771 | |
| 0.049 | 0.023 | 0.069 | Parathyroid hormone antagonist | 0.058 0.013 DBMET02771 0.058 0.013 DBMET02772 0.069 0.007 DBMET02773 | DBMET02773 | |
| 0.032 | 0.006 | 0.045 | Vitamin D receptor antagonist | 0.036 0.005 DBMET02771 0.035 0.006 DBMET02772 0.045 0.005 DBMET02773 | DBMET02773 | |
| 0.06 | 0.034 | 0.069 | Ribonucleoside-diphosphate reductase inhibitor | 0.058 0.035 DBMET02771 0.069 0.029 DBMET02773 | DBMET02773 | |
| 0.061 | 0.036 | 0.071 | Ribonucleotide reductase inhibitor | 0.059 0.037 DBMET02771 0.071 0.031 DBMET02773 | DBMET02773 | |
| 0.032 | 0.009 | 0.032 | Toll-Like receptor 4 agonist | 0.026 0.019 DBMET02771 | ||
| 0.107 | 0.086 | 0.137 | Aldehyde dehydrogenase inhibitor | 0.137 0.056 DBMET02771 0.107 0.086 DBMET02773 | DBMET02771 | |
| 0.046 | 0.025 | 0.046 | Toll-Like receptor 2 agonist | |||
| 0.047 | 0.027 | 0.103 | Macrophage elastase inhibitor | 0.071 0.014 DBMET02771 0.066 0.016 DBMET02772 0.103 0.009 DBMET02773 | DBMET02773 | |
| 0.06 | 0.041 | 0.066 | Cathepsin E inhibitor | 0.056 0.046 DBMET02771 0.057 0.045 DBMET02772 0.066 0.033 DBMET02773 | DBMET02773 | |
| 0.053 | 0.034 | 0.148 | Aconitate hydratase inhibitor | 0.132 0.005 DBMET02771 0.11 0.007 DBMET02772 0.148 0.004 DBMET02773 | DBMET02773 | |
| 0.102 | 0.086 | 0.158 | Cell adhesion inhibitor | 0.147 0.048 DBMET02771 0.112 0.073 DBMET02772 0.158 0.042 DBMET02773 | DBMET02773 | |
| 0.073 | 0.056 | 0.1 | Vanilloid 4 agonist | 0.1 0.017 DBMET02771 0.082 0.037 DBMET02772 0.09 0.026 DBMET02773 | DBMET02771 | |
| 0.044 | 0.028 | 0.054 | HIV-1 protease inhibitor | 0.044 0.028 DBMET02771 0.044 0.029 DBMET02772 0.054 0.017 DBMET02773 | DBMET02773 | |
| 0.059 | 0.044 | 0.061 | Neuraminidase inhibitor | 0.061 0.042 DBMET02773 | DBMET02773 | |
| 0.031 | 0.017 | 0.064 | Leukotriene B4 receptor 1 antagonist | 0.052 0.006 DBMET02771 0.04 0.012 DBMET02772 0.064 0.005 DBMET02773 | DBMET02773 | |
| 0.04 | 0.026 | 0.061 | Membrane dipeptidase inhibitor | 0.061 0.01 DBMET02771 0.045 0.02 DBMET02772 0.046 0.019 DBMET02773 | DBMET02771 | |
| 0.088 | 0.075 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | 0.084 0.083 DBMET02771 0.088 0.076 DBMET02773 | ||
| 0.096 | 0.083 | 0.149 | Mucolytic | 0.135 0.042 DBMET02771 0.12 0.054 DBMET02772 0.149 0.033 DBMET02773 | DBMET02773 | |
| 0.025 | 0.012 | 0.05 | Leukotriene B4 receptor 2 antagonist | 0.039 0.005 DBMET02771 0.032 0.008 DBMET02772 0.05 0.004 DBMET02773 | DBMET02773 | |
| 0.023 | 0.01 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.022 0.012 DBMET02771 0.024 0.009 DBMET02772 0.026 0.007 DBMET02773 | DBMET02773 | |
| 0.1 | 0.088 | 0.207 | Photosensitizer | 0.137 0.04 DBMET02771 0.119 0.058 DBMET02772 0.207 0.011 DBMET02773 | DBMET02773 | |
| 0.18 | 0.168 | 0.18 | Transcription factor STAT inhibitor | |||
| 0.085 | 0.073 | 0.152 | Prolactin inhibitor | 0.152 0.021 DBMET02771 0.103 0.052 DBMET02772 0.114 0.043 DBMET02773 | DBMET02771 | |
| 0.085 | 0.074 | 0.103 | ABCA1 expression enhancer | 0.087 0.071 DBMET02771 0.093 0.06 DBMET02772 0.103 0.046 DBMET02773 | DBMET02773 | |
| 0.015 | 0.005 | 0.016 | Calcineurin inhibitor | 0.016 0.004 DBMET02771 0.015 0.005 DBMET02772 0.01 0.009 DBMET02773 | DBMET02771 | |
| 0.103 | 0.093 | 0.226 | Amylase inhibitor | 0.182 0.05 DBMET02771 0.136 0.071 DBMET02772 0.226 0.036 DBMET02773 | DBMET02773 | |
| 0.031 | 0.021 | 0.031 | Elastase 2B inhibitor | |||
| 0.031 | 0.021 | 0.031 | Elastase 3B inhibitor | |||
| 0.031 | 0.021 | 0.031 | Elastase 3A inhibitor | |||
| 0.061 | 0.052 | 0.061 | Neuraminidase (influenza) inhibitor | |||
| 0.022 | 0.013 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | 0.023 0.011 DBMET02771 0.022 0.013 DBMET02773 | DBMET02771 | |
| 0.023 | 0.015 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET02773 | ||
| 0.162 | 0.155 | 0.162 | DNA damaging | |||
| 0.176 | 0.169 | 0.213 | Lipoxygenase inhibitor | 0.213 0.128 DBMET02771 0.19 0.151 DBMET02772 | DBMET02771 | |
| 0.051 | 0.045 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 DBMET02771 0.051 0.044 DBMET02772 0.062 0.03 DBMET02773 | DBMET02771 | |
| 0.119 | 0.112 | 0.254 | Insulin secretagoues | 0.122 0.107 DBMET02771 0.119 0.113 DBMET02772 0.254 0.019 DBMET02773 | DBMET02773 | |
| 0.064 | 0.058 | 0.064 | Exportin-1 inhibitor | |||
| 0.067 | 0.062 | 0.089 | CDC25A inhibitor | 0.089 0.035 DBMET02771 0.069 0.058 DBMET02773 | DBMET02771 | |
| 0.091 | 0.088 | 0.118 | Protein-tyrosine phosphatase 1B inhibitor | 0.118 0.064 DBMET02771 0.103 0.075 DBMET02773 | DBMET02771 | |
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.021 | 0.018 | 0.037 | CYP24 inhibitor | 0.025 0.013 DBMET02771 0.029 0.011 DBMET02772 0.037 0.008 DBMET02773 | DBMET02773 | |
| 0.031 | 0.028 | 0.1 | Fumarate hydratase inhibitor | 0.071 0.008 DBMET02771 0.072 0.008 DBMET02772 0.1 0.005 DBMET02773 | DBMET02773 | |
| 0.066 | 0.064 | 0.101 | Glycine receptor agonist | 0.09 0.028 DBMET02771 0.073 0.048 DBMET02772 0.101 0.02 DBMET02773 | DBMET02773 | |
| 0.015 | 0.015 | 0.057 | G-protein-coupled receptor 120 agonist | 0.038 0.004 DBMET02771 0.024 0.007 DBMET02772 0.057 0.004 DBMET02773 | DBMET02773 | |
| 0.077 | 0.079 | 0.087 | Interleukin 5 antagonist | 0.085 0.063 DBMET02771 0.086 0.061 DBMET02772 0.087 0.06 DBMET02773 | DBMET02773 | |
| 0.039 | 0.041 | 0.09 | Mannosidase inhibitor | 0.06 0.017 DBMET02771 0.057 0.019 DBMET02772 0.09 0.007 DBMET02773 | DBMET02773 | |
| 0.032 | 0.037 | 0.049 | Glutamate (mGluR8) antagonist | 0.042 0.014 DBMET02771 0.042 0.015 DBMET02772 0.049 0.009 DBMET02773 | DBMET02773 | |
| 0.031 | 0.036 | 0.038 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET02772 0.038 0.023 DBMET02773 | DBMET02773 | |
| 0.061 | 0.067 | 0.178 | Aminopeptidase I inhibitor | 0.109 0.023 DBMET02771 0.13 0.017 DBMET02772 0.178 0.009 DBMET02773 | DBMET02773 | |
| 0.239 | 0.245 | 0.429 | 5 Hydroxytryptamine release inhibitor | 0.265 0.208 DBMET02771 0.293 0.173 DBMET02772 0.429 0.062 DBMET02773 | DBMET02773 | |
| 0.036 | 0.044 | 0.051 | Kainate receptor agonist | 0.051 0.013 DBMET02771 0.048 0.016 DBMET02772 0.05 0.014 DBMET02773 | DBMET02771 | |
| 0.024 | 0.033 | 0.035 | Hedgehog signaling activator | 0.028 0.017 DBMET02771 0.026 0.023 DBMET02772 0.035 0.006 DBMET02773 | DBMET02773 | |
| 0.113 | 0.122 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 DBMET02771 0.122 0.112 DBMET02773 | DBMET02771 | |
| 0.021 | 0.031 | 0.031 | Vanilloid 2 agonist | 0.031 0.008 DBMET02773 | DBMET02773 | |
| 0.065 | 0.076 | 0.114 | Keratolytic | 0.106 0.027 DBMET02771 0.098 0.031 DBMET02772 0.114 0.024 DBMET02773 | DBMET02773 | |
| 0.195 | 0.207 | 0.304 | Toll-Like receptor 7 agonist | 0.275 0.127 DBMET02771 0.251 0.147 DBMET02772 0.304 0.107 DBMET02773 | DBMET02773 | |
| 0.102 | 0.115 | 0.143 | Interleukin 4 antagonist | 0.122 0.083 DBMET02771 0.143 0.057 DBMET02773 | DBMET02773 | |
| 0.047 | 0.06 | 0.096 | Sphingosine 1-phosphate receptor 5 agonist | 0.065 0.02 DBMET02771 0.055 0.034 DBMET02772 0.096 0.009 DBMET02773 | DBMET02773 | |
| 0.029 | 0.044 | 0.098 | Glutamate (mGluR3) antagonist | 0.043 0.018 DBMET02771 0.046 0.015 DBMET02772 0.098 0.004 DBMET02773 | DBMET02773 | |
| 0.027 | 0.042 | 0.076 | G protein-coupled receptor agonist | 0.076 0.009 DBMET02773 | DBMET02773 | |
| 0.016 | 0.035 | 0.026 | Leukotriene D4 antagonist | 0.026 0.018 DBMET02771 0.023 0.021 DBMET02772 | DBMET02771 | |
| 0.036 | 0.055 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.048 0.027 DBMET02773 | DBMET02773 | |
| 0.041 | 0.061 | 0.052 | Squalene epoxidase inhibitor | 0.048 0.038 DBMET02771 0.052 0.031 DBMET02773 | DBMET02773 | |
| 0.022 | 0.043 | 0.041 | Peroxisome proliferator-activated receptor delta agonist | 0.041 0.016 DBMET02773 | DBMET02773 | |
| 0.081 | 0.103 | 0.108 | Phosphodiesterase 6D inhibitor | 0.094 0.065 DBMET02771 0.108 0.039 DBMET02773 | DBMET02773 | |
| 0.071 | 0.096 | 0.234 | Triose-phosphate isomerase inhibitor | 0.14 0.023 DBMET02771 0.143 0.022 DBMET02772 0.234 0.008 DBMET02773 | DBMET02773 | |
| 0.074 | 0.099 | 0.081 | Thioredoxin inhibitor | 0.081 0.08 DBMET02771 | DBMET02771 | |
| 0.043 | 0.074 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET02773 | DBMET02773 | |
| 0.037 | 0.073 | 0.048 | Cathepsin D inhibitor | 0.048 0.044 DBMET02773 | DBMET02773 | |
| 0.054 | 0.091 | 0.101 | Glutamate (mGluR6) antagonist | 0.078 0.026 DBMET02771 0.076 0.03 DBMET02772 0.101 0.01 DBMET02773 | DBMET02773 | |
| 0.017 | 0.054 | 0.031 | Plasmepsin I inhibitor | 0.031 0.02 DBMET02773 | DBMET02773 | |
| 0.071 | 0.108 | 0.08 | Hematopoietic | 0.08 0.074 DBMET02773 | DBMET02773 | |
| 0.039 | 0.077 | 0.148 | Carbamoyl phosphate synthetase inhibitor | 0.095 0.022 DBMET02771 0.096 0.022 DBMET02772 0.148 0.011 DBMET02773 | DBMET02773 | |
| 0.047 | 0.084 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.048 DBMET02773 | DBMET02773 | |
| 0.019 | 0.057 | 0.025 | Retinoid X gamma receptor antagonist | 0.025 0.024 DBMET02772 | DBMET02772 | |
| 0.013 | 0.054 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.008 DBMET02773 | DBMET02773 | |
| 0.075 | 0.116 | 0.146 | Cystathionine beta-synthase inhibitor | 0.146 0.043 DBMET02771 0.12 0.058 DBMET02772 0.131 0.05 DBMET02773 | DBMET02771 | |
| 0.115 | 0.158 | 0.303 | Anesthetic general | 0.146 0.118 DBMET02771 0.138 0.127 DBMET02772 0.303 0.032 DBMET02773 | DBMET02773 | |
| 0.089 | 0.132 | 0.119 | Cathepsin H inhibitor | 0.119 0.076 DBMET02773 | DBMET02773 | |
| 0.059 | 0.103 | 0.085 | Cell adhesion molecule inhibitor | 0.082 0.05 DBMET02771 0.085 0.047 DBMET02773 | DBMET02773 | |
| 0.173 | 0.217 | 0.306 | 5 Hydroxytryptamine uptake stimulant | 0.24 0.092 DBMET02771 0.215 0.124 DBMET02772 0.306 0.042 DBMET02773 | DBMET02773 | |
| 0.007 | 0.052 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.015 DBMET02773 | DBMET02773 | |
| 0.036 | 0.083 | 0.073 | Alpha-mannosidase inhibitor | 0.049 0.047 DBMET02771 0.051 0.042 DBMET02772 0.073 0.015 DBMET02773 | DBMET02773 | |
| 0.069 | 0.119 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.057 DBMET02773 | DBMET02773 | |
| 0.016 | 0.067 | 0.054 | 5-Alpha-reductase inhibitor | 0.054 0.017 DBMET02773 | DBMET02773 | |
| 0.021 | 0.074 | 0.044 | Peroxisome proliferator-activated receptor delta antagonist | 0.044 0.012 DBMET02773 | DBMET02773 | |
| 0.078 | 0.131 | 0.099 | Folate antagonist | 0.099 0.067 DBMET02771 0.092 0.081 DBMET02773 | DBMET02771 | |
| 0.067 | 0.122 | 0.291 | GABA C receptor agonist | 0.214 0.018 DBMET02771 0.216 0.018 DBMET02772 0.291 0.01 DBMET02773 | DBMET02773 | |
| 0.058 | 0.114 | 0.186 | Aminopeptidase B inhibitor | 0.127 0.049 DBMET02771 0.132 0.046 DBMET02772 0.186 0.025 DBMET02773 | DBMET02773 | |
| 0.031 | 0.088 | 0.198 | Alcohol oxidase inhibitor | 0.057 0.038 DBMET02771 0.085 0.022 DBMET02772 0.198 0.007 DBMET02773 | DBMET02773 | |
| 0.183 | 0.241 | 0.286 | Calcium channel activator | 0.286 0.106 DBMET02773 | DBMET02773 | |
| 0.045 | 0.104 | 0.13 | Glutamate decarboxylase inhibitor | 0.106 0.026 DBMET02771 0.091 0.035 DBMET02772 0.13 0.018 DBMET02773 | DBMET02773 | |
| 0.01 | 0.071 | 0.048 | Sphingosine 1-phosphate receptor 3 agonist | 0.048 0.017 DBMET02773 | DBMET02773 | |
| 0.012 | 0.078 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.017 DBMET02773 | DBMET02773 | |
| 0.009 | 0.078 | 0.051 | Arginase inhibitor | 0.034 0.027 DBMET02771 0.051 0.014 DBMET02773 | DBMET02773 | |
| 0.02 | 0.092 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 DBMET02773 | DBMET02773 | |
| 0.003 | 0.076 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.006 DBMET02773 | DBMET02773 | |
| 0.012 | 0.087 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET02773 | DBMET02773 | |
| 0.005 | 0.081 | 0.069 | Free fatty acid receptor 1 agonist | 0.069 0.004 DBMET02773 | DBMET02773 | |
| 0.03 | 0.109 | 0.224 | Biliverdin reductase inhibitor | 0.077 0.028 DBMET02771 0.103 0.017 DBMET02772 0.224 0.005 DBMET02773 | DBMET02773 | |
| 0.036 | 0.116 | 0.072 | Catalase inhibitor | 0.072 0.053 DBMET02773 | DBMET02773 | |
| 0.079 | 0.16 | 0.167 | Thrombolytic | 0.143 0.087 DBMET02771 0.167 0.069 DBMET02773 | DBMET02773 | |
| 0.02 | 0.103 | 0.059 | Sphingosine 1-phosphate receptor 1 agonist | 0.059 0.014 DBMET02773 | DBMET02773 | |
| 0.024 | 0.11 | 0.046 | Thymidine kinase inhibitor | 0.046 0.022 DBMET02773 | DBMET02773 | |
| 0.025 | 0.114 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.03 DBMET02773 | DBMET02773 | |
| 0.019 | 0.108 | 0.041 | GABA uptake inhibitor | 0.041 0.025 DBMET02773 | DBMET02773 | |
| 0.112 | 0.202 | 0.214 | Succinate dehydrogenase inhibitor | 0.173 0.076 DBMET02771 0.18 0.067 DBMET02772 0.214 0.039 DBMET02773 | DBMET02773 | |
| 0.048 | 0.139 | 0.088 | Glycine receptor antagonist | 0.077 0.061 DBMET02771 0.088 0.046 DBMET02773 | DBMET02773 | |
| 0.085 | 0.185 | 0.222 | Psychostimulant | 0.222 0.069 DBMET02773 | DBMET02773 | |
| 0.018 | 0.119 | 0.059 | Ornithine carbamoyltransferase inhibitor | 0.059 0.032 DBMET02773 | DBMET02773 | |
| 0.032 | 0.137 | 0.237 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 DBMET02771 0.095 0.028 DBMET02772 0.237 0.005 DBMET02773 | DBMET02773 | |
| 0.024 | 0.131 | 0.05 | Beta 1 adrenoreceptor antagonist | 0.05 0.047 DBMET02773 | DBMET02773 | |
| 0.041 | 0.153 | 0.103 | GABA aminotransferase inhibitor | 0.074 0.055 DBMET02771 0.077 0.051 DBMET02772 0.103 0.025 DBMET02773 | DBMET02773 | |
| 0.08 | 0.195 | 0.155 | Diuretic | 0.155 0.073 DBMET02773 | DBMET02773 | |
| 0.05 | 0.177 | 0.125 | UDP-glucose 4-epimerase inhibitor | 0.125 0.04 DBMET02773 | DBMET02773 | |
| 0.018 | 0.148 | 0.055 | Sphingosine 1-phosphate receptor agonist | 0.055 0.02 DBMET02773 | DBMET02773 | |
| 0.003 | 0.133 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET02773 | DBMET02773 | |
| 0.02 | 0.155 | 0.046 | Glutamate (mGluR8) agonist | 0.035 0.033 DBMET02772 0.046 0.014 DBMET02773 | DBMET02773 | |
| 0.016 | 0.154 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET02773 | DBMET02773 | |
| 0.025 | 0.17 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | 0.059 0.055 DBMET02771 | DBMET02771 | |
| 0.019 | 0.164 | 0.101 | Argininosuccinate synthase inhibitor | 0.055 0.042 DBMET02772 0.101 0.019 DBMET02773 | DBMET02773 | |
| 0.02 | 0.165 | 0.048 | AICAR transformylase inhibitor | 0.048 0.024 DBMET02773 | DBMET02773 | |
| 0.074 | 0.222 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.081 DBMET02773 | DBMET02773 | |
| 0.009 | 0.166 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 DBMET02773 | DBMET02773 | |
| 0.172 | 0.33 | 0.301 | Calcium channel L-type activator | 0.301 0.157 DBMET02773 | DBMET02773 | |
| 0.036 | 0.203 | 0.163 | Alcohol dehydrogenase inhibitor | 0.163 0.017 DBMET02773 | DBMET02773 | |
| 0.025 | 0.198 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.035 DBMET02773 | DBMET02773 | |
| 0.021 | 0.198 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.035 DBMET02773 | DBMET02773 | |
| 0.047 | 0.226 | 0.114 | NADH dehydrogenase inhibitor | 0.08 0.075 DBMET02772 0.114 0.032 DBMET02773 | DBMET02773 | |
| 0.015 | 0.196 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET02773 | DBMET02773 | |
| 0.037 | 0.227 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.044 DBMET02773 | DBMET02773 | |
| 0.086 | 0.28 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.079 DBMET02773 | DBMET02773 | |
| 0.025 | 0.223 | 0.048 | Bombesin 2 receptor antagonist | 0.048 0.037 DBMET02773 | DBMET02773 | |
| 0.121 | 0.329 | 0.171 | Nitric-oxide synthase stimulant | 0.171 0.149 DBMET02773 | DBMET02773 | |
| 0.026 | 0.249 | 0.104 | Purinergic P2X1 antagonist | 0.104 0.015 DBMET02773 | DBMET02773 | |
| 0.026 | 0.258 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 DBMET02773 | DBMET02773 | |
| 0.018 | 0.271 | 0.074 | Histidine decarboxylase inhibitor | 0.074 0.047 DBMET02773 | DBMET02773 | |
| 0.059 | 0.329 | 0.242 | Aldehyde oxidase inhibitor | 0.242 0.085 DBMET02773 | DBMET02773 | |
| 0.045 | 0.32 | 0.118 | DOPA decarboxylase inhibitor | 0.118 0.048 DBMET02773 | DBMET02773 | |
| 0.023 | 0.301 | 0.08 | Adrenaline agonist | 0.08 0.057 DBMET02773 | DBMET02773 | |
| 0.075 | 0.353 | 0.159 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.137 DBMET02773 | DBMET02773 | |
| 0.016 | 0.299 | 0.131 | Porphobilinogen synthase inhibitor | 0.131 0.025 DBMET02773 | DBMET02773 | |
| 0.031 | 0.314 | 0.107 | GABA C receptor antagonist | 0.107 0.068 DBMET02773 | DBMET02773 | |
| 0.023 | 0.315 | 0.07 | Glutamate (mGluR7) antagonist | 0.07 0.042 DBMET02773 | DBMET02773 | |
| 0.033 | 0.336 | 0.089 | GABA B receptor agonist | 0.089 0.027 DBMET02773 | DBMET02773 | |
| 0.031 | 0.337 | 0.108 | HIV-1 integrase (Overall Integration) inhibitor | 0.108 0.048 DBMET02773 | DBMET02773 | |
| 0.026 | 0.359 | 0.218 | Ferrochelatase inhibitor | 0.218 0.018 DBMET02773 | DBMET02773 | |
| 0.036 | 0.37 | 0.067 | MDM2 inhibitor | 0.067 0.048 DBMET02773 | DBMET02773 | |
| 0.07 | 0.405 | 0.172 | Superoxide dismutase inhibitor | 0.172 0.153 DBMET02773 | DBMET02773 | |
| 0.004 | 0.361 | 0.044 | Free fatty acid receptor 1 antagonist | 0.044 0.013 DBMET02773 | DBMET02773 | |
| 0.031 | 0.395 | 0.101 | Electrolyte absorption antagonist | 0.101 0.056 DBMET02773 | DBMET02773 | |
| 0.039 | 0.41 | 0.115 | Peroxidase inhibitor | 0.115 0.105 DBMET02773 | DBMET02773 | |
| 0.078 | 0.467 | 0.296 | Insulysin inhibitor | 0.195 0.164 DBMET02771 0.188 0.177 DBMET02772 0.296 0.061 DBMET02773 | DBMET02773 | |
| 0.089 | 0.499 | 0.139 | Heat shock protein 70 antagonist | 0.139 0.079 DBMET02773 | DBMET02773 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |